The BACTEC resin-containing blood culture bottle (16B; Johnston Laboratories) was designed to bind antibiotics and to support bacterial growth. However, only modest increases in the recovery rates of pathogens have been found in clinical studies. This in vitro study evaluated the ability of the 16B to recover organisms from human serum containing clinically achievable concentrations of antibiotics. Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Pseudomonas aeruginosa, Haemophilus influenzae, Staphylococcus aureus, Streptococcus faecalis, and a viridans streptococcus were added to serum containing antibiotic(s), and at various time intervals of antibiotic exposure, portions were removed and inoculated into both the 16B and the 6B (conventional aerobic) bottles. The studies of the kinetics of killing of the bacterial strains by the various antibiotics showed a good correlation between those combinations of bacteriaantibiotic(s) which produced slow killing and the combinations of bacteriaantibiotic(s) which were recovered preferentially in the 16B bottles. Low recovery rates were noted when the antibiotics killed the organisms rapidly. The indications for use of the resin-containing blood culture bottle should be limited to those situations in which the patient is receiving antibiotics and the bacteremia is suspected to involve a pathogen which is killed slowly by the administered drug(s) or when the bacteremia is continuous. The failure of the BACTEC 16B blood culture bottle to recover organisms may in part reflect the bactericidal activity of the antibiotics administered.
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In the seriously ill patient, antimicrobial agents may be given before the completion of all diagnostic tests, including the collection of blood cultures. Often a patient may become febrile while on antimicrobial therapy and blood cultures need to be obtained. In both of these clinical situations, isolation of a blood-borne pathogen is desirable and should help in the clinical management of the patient. Unfortunately, the blood cultures obtained more often than not do not yield a viable organism(s) by the conventional methods, possibly due to the presence of antibiotics in the blood. With the increasing number of available antibiotics and the widespread use of broad-spectrum antimicrobial drugs, a device is needed to remove such agents from the blood sample during or before the incubation of the blood culture bottles. Such a device should increase the recovery rate of these pathogens.
The first available antibiotic-binding device was the Antimicrobial Removal Device (ARD; Marion Scientific, Kansas City, Mo.). The ARD contains cationic and anionic resins, SPS, and saline (2, 5) . After the addition of blood, the ARD bottle is rotated for 15 min to enhance antibiotic removal by the resins. Then the blood is removed from the resins and inoculated into conventional blood culture bottles and incubated. The second device is the BACTEC resincontaining blood culture bottle (16B) from Johnston Laboratories, Towson, Md. The 16B bottle is a combination of the aerobic blood culture bottle ( Binding experiments. The resin-containing blood culture bottles (16B) were examined for the ability of the resins within the bottles to bind various antibiotics after inoculation and during incubation. Antibiotics were added to 3 ml of human serum (Flow Laboratories) to make a final concentration of 25 jig of ampicillin, cephalothin, cefoperazone, cefotaxime, moxalactam, or nafcillin per ml, 5 ,ug of gentamicin or tobramycin per ml, or 120 ,g of ticarcillin per ml. The serum was heat inactivated at 56°C for 30 min before use. The serum was added immediately to the 16B resin-containing bottle. The bottles were either rotated at 35°C in a water bath at 200 cycles per min or incubated at a stationary position. After a 15-or 30-min rotation or after a 15-min stationary incubation, 1 ml of Mueller-Hinton broth containing 150 to 300 CFU of E. coli or S. aureus per ml was added to each bottle. The number of CFU per milliliter was equivalent to the total number of organisms inoculated per bottle in later experiments. E. coli was used for all bottles containing antibiotics except for bottles containing nafcillin to which S. aureus was added. Bottles which were agitated before the addition of organisms were again incubated at 35°C in a water bath shaker (American Optical Corp., Buffalo, N.Y.) at 200 cycles per min, and bottles which were incubated at a stationary position before the addition of organisms were placed in a 35°C incubator. After 18 h, all bottles were observed for visible growth and subcultured onto blood agar plates for the detection of viable organisms. mixed. Portions (3 ml) were immediately removed and inoculated into the 16B and the 6B blood culture bottles (time 0). At various time intervals, 3-ml portions of this serum containing antibiotics and organisms were used to inoculate both types of bottles. For serum containing gram-negative rods and the viridans streptococcus, the intervals were 0, 15, and 30 min, 1, 2, and 3 h, and for other gram-positive cocci were 0, 0.5, 1, 2, 4, and 6 h. All blood culture bottles inoculated with H. influenzae were supplemented with 5% 
RESULTS
The MICs of the antibiotics tested and the respective organisms studied are listed in Table   1 . The MICs (c0.3 jxg/ml) of the third-generation cephalosporins were low for the organisms studied. The strain of S. faecalis studied was susceptible to gentamicin (2 ,ug/ml). All MBCs were within one twofold dilution of the MICs with the exception of S. faecalis and ampicillin.
The ability of the resins to bind various antibiotics was studied by adding antibiotics to serum at concentrations which are clinically achievable. Portions (3 ml) of serum containing a study antibiotic or antibiotic combination were added to the resin-containing bottles. Bottles were then either rotated for 15 or 30 min or left stationary to allow for antibiotic binding to the resins. E. coli or S. aureus was then added to the bottles. If the organisms grew, then sufficient quantities of the antibiotics to which the organisms were susceptible were assumed to have been bound to the resins. The results of this experiment are shown in Table 2 . Whether the bottles were rotated or held stationary did not affect the recovery of the test strains for ampicillin, cephalothin, cefoperazone, gentamicin, tobramycin, or nafcillin. However, in the 16B bottles, sufficient amounts of ticarcillin and moxalactam were still available to kill the strain of E. coli tested. Bottles which were left stationary after the addition of cefotaxime were able to support bacterial growth; however, when the bottles were rotated no growth was detected. These same findings were observed on repeated trials.
Various organisms were added to serum containing clinically achievable concentrations of an antibiotic or a combination of antibiotics. The abilities of both the BACTEC resin-containing 16B bottle and the conventional aerobic 6B bottle to recover the added organisms after the various time intervals of antibiotic exposure shown in Table 3 . The maximum time interval of antibiotic exposure studied for the gram-negative rods was 3 h and for the S. aureus and S. faecalis was 6 h. The conventional aerobic bottles failed to recover most organisms even when the mixture of antibiotic-organism-serum was cultured in these bottles immediately after the addition of antibiotics (time 0). The test strains of S. faecalis and the viridans streptococcus were recovered in both the 16B and the 6B bottle even after a prolonged exposure to ampicillin alone. For all test strains exposed to cefotaxime and cefoperazone, viable organisms were recovered from the 16B bottles up to the maximum antibiotic exposure time studied (3 h); however, these same organisms were rarely recovered after exposure to moxalactam. The time interval of antibiotic exposure after which the organisms were recovered was less when antibiotic combinations to which the organisms were susceptible were employed. For the combination of ampicillin and gentamicin, the viridans streptococcus was not recovered by the 16B beyond 15 min of antibiotic exposure as compared to recovery after 3 h of exposure to ampicillin alone. S. faecalis could not be recovered after 1 h of exposure to the drug combination as compared to recovery after 6 h of exposure to ampicillin alone. Markedly decreased recovery rates were also noted for the gram-negative rods after just a brief exposure to antibiotic combinations, and often only those 16B bottles inoculated at time 0 were able to recover viable organisms. Bacterial growth of antibiotic-damaged organisms in the 16B resin-containing blood culture bottle was detected generally within 18 to 24 h of inoculation by visual observation, subculture for all gram-negative rods except H. influenzae (required 48 h of incubation for detectable growth), or both. For S. aureus exposed to nafcillin alone, growth was detected 18 h after inoculation; however, after 2 h of exposure to nafcillin and gentamicin, 4 days were required for the detection of growth, whereas with shorter periods of antibiotic exposure, organisms were detected within 18 h of inoculation. For S. faecalis, all growth was detected after the initial 18-h incubation in both types of bottles. For the viridans streptococcus, 48 h of incubation was required for detectable growth in the 16B bottle after exposure to ampicillin and gentamicin. In general, whenever both the conventional aerobic (6B) and the resin-containing (16B) blood culture bottles yielded viable organisms, growth was detected in both types of bottles on the same day.
The rates of killing of organisms by individual or combinations of antibiotics are shown in Fig.  1 . In general, the rate of killing for the thirdgeneration cephalosporins was relatively slow. Only a 1 to 2 log decrease in CFU was noted after 3 h of exposure of Enterobacter cloacae, Klebsiella pneumoniae, and H. influenzae to moxalactam, cefotaxime, and cefoperazone. The combinations of ampicillin and gentamicin and of cephalothin and gentamicin decreased the number of viable organisms by 5 logs within 1 h for all gram-negative rods studied. A 3 log decrease in 1 h was observed for P. aeruginosa after exposure to ticarcillin (120 ,ug/ml) and tobramycin (5 ,ug/ml), and no viable organisms were detected after 4 h. After a 3-h exposure of the viridans streptococcus and H. influenzae to ampicillin at a concentration of 25 ,ug/ml, the viable counts decreased approximately 1 log. After a 6-h exposure of S. faecalis to ampicillin, a decrease of only 1 log was noted. The combinations of nafcillin and gentamicin or ampicillin and gentamicin markedly decreased the number of organisms recovered as compared to nafcillin or ampicillin alone for S. aureus, S. faecalis, and the viridans streptococcus. DISCUSSION In the critically ill patient with a fever and suspected bacteremia, various antibiotics or combinations of antibiotics are often administered before the collection of appropriate cultures. When the identity of the pathogen is unknown, therapy must be broad spectrum enough to include activity for all the organisms which are suspected. In large or tertiary care facilities, these organisms may include relatively resistant enteric gram-negative rods, staphylococci, and P. aeruginosa, which may dictate the use of certain antimicrobial agents such as moxalactam or antibiotic combinations such as ticarcillin and tobramycin.
Recently, two devices have been made available which contain resins and are reported to bind the antibiotics in the blood samples sent for culture. The ARD and the BACTEC resin-containing blood culture bottle (16B) have been designed to and should aid in the recovery of organisms from patients on antimicrobial therapy. The ARD has been evaluated by several institutions; however, its success as measured by an increased recovery rate of organisms has been modest (3, 5, 6) U., When the kinetics of killing of the various agents were studied, the decrease in the ability to recover organisms after antibiotic exposure from the 16B bottles correlated well with the rate of decrease in the number of viable organisms in the kill curve. E. coli, K. pneumoniae, and E. cloacae were not recovered after a 30-min exposure to ampicillin and gentamicin or cephalothin and gentamicin. The killing kinetics for these antibiotics and organisms also indicated that these organisms were rapidly killed. The combination of ticarcillin and tobramycin also produced a rapid decrease in the number of viable P. aeruginosa, and the 16B bottle recovery of this organism was not possible after the organisms were incubated in this antibiotic combination for greater than 60 min. For antibiotics which killed organisms more slowly (cefotaxime, moxalactam, and cefoperazone), increased recovery of the organisms in the resin-containing bottle was consistently noted. The recovery of the gram-negative rods was greatly increased even when susceptible organisms were exposed to relatively high serum levels for up to 3 h. For gram-positive organisms, S. aureus, S. faecalis, and the viridans streptococcus, increased recovery was noted for the antibiotic combinations of ampicillin and gentamicin or nafcillin and gentamicin as compared to the conventional bottle. These data are consistent with results of clinical studies (1, 2, 5, 6) .
Many factors are important in the successful isolation of a blood-borne pathogen (4) . Both the resin-containing 16B and the conventional 6B aerobic blood culture bottles result in the same final dilution (approximately 1:10) of the blood sample and, hence, the contained antibiotics. For organisms which have relatively high MICs of the administered antibiotics or slow killing or for antibiotics with limited stability in serum and blood, a 1:10 dilution alone by the 6B bottle may be enough to permit bacterial growth. Although the role of SPS cannot be discounted, equal concentrations (0.025%) were contained in both types of bottles. The rate of shedding of the organism into the bloodstream of the host (transient versus continuous) and the timing and rate of infusion of antibiotics may also be determining factors in the recovery of organisms from blood cultures. The length of the incubation of the blood cultures will also affect the recovery rate offastidious and slow-growing organisms as well as possibly antibiotic-exposed organisms.
In conclusion, the data presented suggest that the BACTEC 16B resin-containing blood culture bottle has the potential to increase the recovery rate of antibiotic-exposed microorganisms. However, not all antibiotics are bound or inactivated by the contents of this culture bottle (e.g., moxalactam and ticarcillin). The antibiotic concentration in the serum at the time of blood collection may also influence the success rate for the recovery of the pathogen. The clinician and the laboratory personnel must also be aware that organisms which are killed more slowly are more likely to be recovered from the resincontaining bottles, whereas those organisms which are rapidly killed by appropriate therapy are less likely to be recovered. Awareness of these factors should render the indications for use of the 16B BACTEC system more specific and the interpretation of the culture results more understandable.
